Nasal spray device

- Nemera La Verpilliere
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top perspective view of a nasal spray device incorporating our design.

FIG. 2 is a top view thereof.

FIG. 3 is a rear view thereof.

FIG. 4 is a right side view thereof.

FIG. 5 is a bottom perspective view thereof; and,

FIG. 6 is a front view thereof.

The broken lines shown in the drawings depict portions of the nasal spray device that form no part of the claimed design.

Claims

We claim the ornamental design for a nasal spray device, as shown and described.

Referenced Cited
U.S. Patent Documents
D433123 October 31, 2000 Sheppard
D686312 July 16, 2013 Allsop
D860435 September 17, 2019 Wang
D890330 July 14, 2020 Wang
D993389 July 25, 2023 Graine
D993390 July 25, 2023 Graine
D998138 September 5, 2023 Espinoza
11759586 September 19, 2023 Ferrer
D1001997 October 17, 2023 Graine
20040124213 July 1, 2004 Gillissen
20140231457 August 21, 2014 Allsop
20140263457 September 18, 2014 Barber
20160166780 June 16, 2016 Allsop
20180185593 July 5, 2018 Nyirucz
20200009081 January 9, 2020 Wang
20230390506 December 7, 2023 Graine
Foreign Patent Documents
6226765 March 2023 GB
Other references
  • “FDA approves esketamine nasal spray” by Catherine Shu. Published: Mar. 5, 2019. Retrieval date: Aug. 26, 2023. Retrieved from internet:https://techcrunch.com/2019/03/05/fda-approves-esketamine-nasal-spray-the-first-new-major-depression-drug-in-more-than-30-years/ (Year: 2019).
Patent History
Patent number: D1028214
Type: Grant
Filed: Jun 30, 2022
Date of Patent: May 21, 2024
Assignee: Nemera La Verpilliere (La Verpiliere)
Inventors: Gaetan Painchaud (Francheville), Guillaume Cerqueira (Lyons)
Primary Examiner: Daniel J Domino
Assistant Examiner: Lee D. Starr
Application Number: 29/844,653
Classifications
Current U.S. Class: Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)